Neola Medical AB
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden. It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume chan… Read more
Neola Medical AB (NEOLA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.033x
Based on the latest financial reports, Neola Medical AB (NEOLA) has a cash flow conversion efficiency ratio of -0.033x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.57 Million) by net assets (Skr78.46 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neola Medical AB - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Neola Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neola Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neola Medical AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lead Real Estate Co., Ltd American Depositary Shares
NASDAQ:LRE
|
94.590x |
|
D'IETEREN (DJDA.SG)
STU:DJDA
|
N/A |
|
Grupo Mexicano de Desarrollo S.A.B
PINK:GMXDF
|
0.040x |
|
Djasa Ubersakti Tbk
JK:PTDU
|
-5.449x |
|
STAGEZERO LIFE SCIENC.
F:61N1
|
N/A |
|
WestKam Gold Corp
PINK:WKGFF
|
0.065x |
|
OBAL11
SA:OBAL11
|
N/A |
|
Etga Group Ltd
TA:ETGA
|
0.014x |
Annual Cash Flow Conversion Efficiency for Neola Medical AB (2018–2024)
The table below shows the annual cash flow conversion efficiency of Neola Medical AB from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr68.96 Million | Skr-10.84 Million | -0.157x | -89.83% |
| 2023-12-31 | Skr79.03 Million | Skr-6.54 Million | -0.083x | +34.25% |
| 2022-12-31 | Skr67.48 Million | Skr-8.50 Million | -0.126x | +26.18% |
| 2021-12-31 | Skr40.63 Million | Skr-6.93 Million | -0.171x | +33.89% |
| 2020-12-31 | Skr23.55 Million | Skr-6.08 Million | -0.258x | -33.84% |
| 2019-12-31 | Skr10.72 Million | Skr-2.07 Million | -0.193x | -94.79% |
| 2018-12-31 | Skr13.33 Million | Skr-1.32 Million | -0.099x | -- |